# HLT Meridian Valve CE Mark Trial

> **NCT03805711** · NA · TERMINATED · sponsor: **HLT Inc.** · enrollment: 1 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** HLT® Transcatheter System

## Key facts

- **NCT ID:** NCT03805711
- **Lead sponsor:** HLT Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-12
- **Primary completion:** 2019-09-20
- **Final completion:** 2019-09-20
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Sponsor decision to stop enrollment.
- **Last updated:** 2020-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03805711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03805711, "HLT Meridian Valve CE Mark Trial". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03805711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*